Document is current
Any future updates will be listed below
-
Authors
Lyu, Ruitu http://orcid.org/0000-0003-4597-1604
Gao, Yun
Wu, Tong http://orcid.org/0000-0001-9968-9909
Ye, Chang http://orcid.org/0000-0003-0236-5671
Wang, Pingluan
He, Chuan http://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (RM1HG008935, R01HG012780)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 6 March 2024
Accepted: 18 July 2024
First Online: 10 August 2024
Competing interests
: C.H. serves as a scientific co-founder and a member of the scientific advisory board for Aferna Green, Inc. and AccuaDX Inc. Additionally, C.H. holds equity in both Aferna Green, Inc. and Accent Therapeutics, Inc. T.W. is a shareholder of AccuraDX Inc. The remaining authors declare no competing interests.
